Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Number of patients with increased disease severityTimepoint: From baseline to at any time during the study till 28 days post first dosing.	Number of patients with increased disease severityTimepoint: From baseline to at any time during the study till 28 days post first dosing.
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	Number of patients with increased disease severityTimepoint: From baseline to at any time during the study till 28 days post first dosing.	Number of patients with increased disease severityTimepoint: From baseline to at any time during the study till 28 days post first dosing.